Local News

• Wyeth wins Philadelphia diet drug trial involving claim of PPH  Wyeth announced that the jury in the case of Danny Crowder (Individually and as Administrator of the Estate of Edna Faye Crowder) v. Wyeth in the Philadelphia Court of Common Pleas found in favor of Wyeth.
  Wyeth October 10, 2008  
• Introducing Pediatric Care Online(TM)  The American Academy of Pediatrics (AAP) is introducing a revolutionary, next-generation point-of-practice resource to the nation's pediatricians this week as the organization holds its annual National Conference & Exhibition.
  Bristol-Myers Squibb Company October 10, 2008  
• ROTATEQ(R) receives WHO pre-qualification  ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent), the pentavalent rotavirus vaccine from Merck & Co. that helps prevent rotavirus gastroenteritis in infants and children, has been awarded pre-qualification status by the World Health Organization (WHO).
  Merck & Co., Inc. October 10, 2008  
• Lilly recognized as one of the world's Top Biopharmaceutical Employers  Eli Lilly and Company announced that it has made the list of Top 20 biopharmaceutical employers, according to the prestigious peer-reviewed journal Science.
  Eli Lilly and Company October 10, 2008  
• FDA approves AstraZeneca's Seroquel XR for the treatment of bipolar depression  AstraZeneca announced that the FDA has approved once-daily SEROQUEL XR Extended-Release Tablets for the acute treatment of the depressive episodes associated with bipolar disorder, the manic and mixed episodes associated with bipolar I disorder, and the maintenance treatment of bipolar I disorder.
  AstraZeneca October 10, 2008  
• FDA approves new injection site for RISPERDAL(R) CONSTA(R) for schizophrenia treatment  Patients with schizophrenia now have a new administration option for RISPERDAL(R) CONSTA(R). The U.S. Food and Drug Administration (FDA) has approved a new injection site, the deltoid muscle in the arm, for RISPERDAL CONSTA for the treatment of patients with schizophrenia.
  Johnson & Johnson October 09, 2008  
• Monsanto recognized as Top Biotechnology Employer by Science Magazine  Monsanto Company is earning recognition as a leader in biotechnology not just for its ground-breaking products but also for being a great place to work.
  Monsanto Company October 09, 2008  
• Genzyme recognized by scientists as a top employer  Genzyme announced that scientists have again named the company a top employer in a survey ranking the reputations of biotechnology and pharmaceutical companies.
  Genzyme Corporation October 09, 2008  
• Johnson & Johnson announces executive appointments  Johnson & Johnson announced that Sheri McCoy, currently Worldwide Chairman, Surgical Care Group, has been appointed Worldwide Chairman, Pharmaceuticals Group, effective January 1, 2009.
  Johnson & Johnson October 09, 2008  
• EPA honors Pfizer for reducing greenhouse gas emissions  The U.S. Environmental Protection Agency (EPA) honored Pfizer in recognition of the company's award-winning Energy and Climate Change Program, which reduced total greenhouse gas emissions by 43 percent per million dollars of revenue from 2000 to 2007.
  Pfizer Inc. October 08, 2008  

   (next 10 articles)